Retinopathy of Prematurity (ROP)
23
5
5
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
8.7%
2 terminated out of 23 trials
81.8%
-4.7% vs benchmark
17%
4 trials in Phase 3/4
56%
5 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (23)
Safety, PK and PD of FLQ-101 in Premature Neonates
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Retinopathy of Prematurity - Visual Function and Retinal Structure
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
ROP Check Database Premature Infant Outcomes
Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090
The Correlation Between Red Cell Transfusion and Complications of Prematurity
Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants
Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity
Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy
To Assess the Effect of Dexamethasone Eye Drops on the Retinopathy of Prematurity Outcome
A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China
The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination
Long-term Ophthalmic Outcomes in Ex-premature Infants
Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Rainbow Extension Study
Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Inositol to Reduce Retinopathy of Prematurity